These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 9381537

  • 1. Safety of the mycophenolate mofetil-allopurinol combination in kidney transplant recipients with gout.
    Jacobs F, Mamzer-Bruneel MF, Skhiri H, Thervet E, Legendre C, Kreis H.
    Transplantation; 1997 Oct 15; 64(7):1087-8. PubMed ID: 9381537
    [No Abstract] [Full Text] [Related]

  • 2. Safety of the allopurinol-mycophenolate mofetil combination in the treatment of hyperuricemia of kidney transplant recipients.
    Navascués RA, Gómez E, Rodriguez M, Laures AS, Baltar J, Grande JA.
    Nephron; 2002 May 15; 91(1):173-4. PubMed ID: 12021539
    [No Abstract] [Full Text] [Related]

  • 3. Cyclosporine-induced hyperuricemia and gout in renal transplants.
    Ben Hmida M, Hachicha J, Bahloul Z, Kaddour N, Kharrat M, Jarraya F, Jarraya A.
    Transplant Proc; 1995 Oct 15; 27(5):2722-4. PubMed ID: 7482890
    [No Abstract] [Full Text] [Related]

  • 4. Dermal tophus: a complication of gout in a kidney transplant recipient.
    Ayvazoglu Soy EH, Karakaya E, Karatas Togral A, Akdur A, Moray G, Haberal M.
    Exp Clin Transplant; 2015 Apr 15; 13 Suppl 1():276-9. PubMed ID: 25894172
    [Abstract] [Full Text] [Related]

  • 5. [Allopurinol efficacy in patients with tophus gout and chronic renal failure].
    Iakunina IA, Barskova VG, Nasonova VA.
    Ter Arkh; 2006 Apr 15; 78(6):88-91. PubMed ID: 16881370
    [No Abstract] [Full Text] [Related]

  • 6. Case 9: initiation of urate-lowering therapy for advanced gout complicated by chronic renal insufficiency.
    Edwards NL.
    Am J Med; 2006 Nov 15; 119(11 Suppl 1):S29-31. PubMed ID: 17059911
    [No Abstract] [Full Text] [Related]

  • 7. High mycophenolic acid area under-the-curve values in renal transplant recipients on long-term mycophenolate mofetil treatment.
    Engelbertink R, Smak Gregoor P, Hesse C, IJzermans J, Weimar W, van Gelder T.
    Transplant Proc; 2002 Nov 15; 34(7):2983-4. PubMed ID: 12431677
    [No Abstract] [Full Text] [Related]

  • 8. Lesinurad/Allopurinol (Duzallo) for Gout-Associated Hyperuricemia.
    JAMA; 2018 Jan 09; 319(2):188-189. PubMed ID: 29318274
    [No Abstract] [Full Text] [Related]

  • 9. Mycophenolate mofetil immunosuppression in high-risk renal transplant recipients.
    Abouna GM, al Arrayed AS, Farid E, Awad CK, Sharqawi SA, Tantawi M.
    Transplant Proc; 1998 Dec 09; 30(8):4077-8. PubMed ID: 9865302
    [No Abstract] [Full Text] [Related]

  • 10. Omission of azathioprine and mycophenolate mofetil in immunosuppressive regimen in kidney transplantation.
    Taheri M, Pourmand G, Mehrsai AR, Mansoori D.
    Transplant Proc; 2003 Nov 09; 35(7):2752-3. PubMed ID: 14612105
    [No Abstract] [Full Text] [Related]

  • 11. Gout: beyond the stereotype.
    Jones RE, Ball EV.
    Hosp Pract (1995); 1999 Jun 15; 34(6):95-102; discussion 102-3; quiz 133. PubMed ID: 10386113
    [Abstract] [Full Text] [Related]

  • 12. Treatment of gout.
    Cohen MG.
    Intern Med J; 2011 Jan 15; 41(1a):70-1. PubMed ID: 21265967
    [No Abstract] [Full Text] [Related]

  • 13. Randomized trial of tacrolimus in combination with mycophenolate mofetil versus cyclosporine with mycophenolate mofetil in cadaveric renal transplant recipients with delayed graft function.
    Liu B, Lin ZB, Ming CS, Zhang WJ, Chen ZS, Sha B, Zeng FJ, Chen S.
    Transplant Proc; 2003 Feb 15; 35(1):87-8. PubMed ID: 12591319
    [No Abstract] [Full Text] [Related]

  • 14. Lymphocyte subsets in renal transplant recipients treated with mycophenolate mofetil.
    François M, Büchler M, Halimi JM, Al-Najjar A, Valentin JF, Thibault G, Lebranchu Y.
    Transplant Proc; 2000 Dec 15; 32(8):2781-2. PubMed ID: 11134803
    [No Abstract] [Full Text] [Related]

  • 15. Mycophenolate mofetil versus azathioprine in simultaneous pancreas-kidney transplant recipients on cyclosporine.
    Fabrega AJ, Corwin CL, Hunsicker L.
    Transplant Proc; 1998 Jun 15; 30(4):1562-3. PubMed ID: 9636634
    [No Abstract] [Full Text] [Related]

  • 16. Efficacy and safety of daclizumab induction for primary kidney transplant recipients in combination with tacrolimus, mycophenolate mofetil, and steroids as maintenance immunosuppression.
    Ciancio G, Burke GW, Suzart K, Vaidya A, Roth D, Kupin W, Mattiazzi A, Rosen A, Esquenazi V, Miller J.
    Transplant Proc; 2003 Mar 15; 35(2):873-4. PubMed ID: 12644172
    [No Abstract] [Full Text] [Related]

  • 17. Co-administration of tacrolimus and mycophenolate mofetil in cadaveric renal transplant recipients.
    Vanrenterghem Y, Squifflet JP, Forsythe J, Heeman U, Bäckman L, Taube D, Morales JM, Ekberg H, van Hooff J, Zanker B, Dietl KH, Talbot D, Hauser I, Tydén G, Claesson K, Mühlbacher F.
    Transplant Proc; 1998 Jun 15; 30(4):1290-1. PubMed ID: 9636523
    [No Abstract] [Full Text] [Related]

  • 18. Treatment of gout after transplantation.
    Perez-Ruiz F, Alonso-Ruiz A, Calabozo M, Duruelo J.
    Br J Rheumatol; 1998 May 15; 37(5):580. PubMed ID: 9651090
    [No Abstract] [Full Text] [Related]

  • 19. Successful use of allopurinol in a patient on dialysis.
    Day RO, Kannangara DR, Hayes JM, Furlong TJ.
    BMJ Case Rep; 2012 Jun 05; 2012():. PubMed ID: 22675142
    [Abstract] [Full Text] [Related]

  • 20. [Tophaceous gout causing stenosis of T11-T12].
    Rivero-Garvía M, Rodríguez Boto G, Gutiérrez González R, Martínez A.
    Med Clin (Barc); 2008 Apr 05; 130(12):479. PubMed ID: 18405510
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.